These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 6175933)

  • 1. [Preliminary results of a chemotherapy study of patients with squamous cell carcinoma in the head and neck region. Comparison of 2 therapeutic regimens: cis-diamminodichloroplatinum (II) and bleomycin compared to methotrexate and vindesine].
    von Heyden HW; Beyer JH; Matthaei A; Nagel GA; Schröder M
    Onkologie; 1981 Dec; 4(6):296-9. PubMed ID: 6175933
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Treatment of epidermoid head and neck cancer with cisplatinum/bleomycin vs methotrexate/vindesine].
    Schröder M; von Heyden HW; Beyer JH; Klee M
    Laryngol Rhinol Otol (Stuttg); 1981 Jun; 60(6):331-3. PubMed ID: 6167831
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [2d interim evaluation of a chemotherapy study on patients with squamous cell carcinomas of the head-neck area. A comparison of 2 therapy regimens: cis-diamminedichloroplatinum (II) and bleomycin versus methotrexate and vindesine].
    Schröder M; von Heyden HW; Scherpe A; Borghardt J; Beyer JH; Nagel GA; Gerhartz H; Kastenbauer E; Westerhausen M; Schroeder M; Caliebe W; Rudert H; Lissers R; Hofmann J; Schneider B
    Onkologie; 1983 Jun; 6(3):114-7. PubMed ID: 6193472
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Cytostatic therapy of advanced squamous cell carcinoma of the head and neck. A randomized study comparing cis-dichlorodiammineplatinum(II) and bleomycin with methotrexate and vindesine].
    von Heyden HW; Schröder M; Scherpe A; Beyer JH; Kaboth U; Stennert E; Nagel GA; Gerhartz H; Foth B; Kastenbauer E
    Onkologie; 1984 Jun; 7(3):183-90. PubMed ID: 6205337
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Phase II study of methotrexate, vinblastine, doxorubicin, and cisplatin in patients with squamous cell carcinoma of the upper respiratory or alimentary passages of the head and neck.
    Okuno SH; Mailliard JA; Suman VJ; Edmonson JH; Creagan ET; Nair S; Levitt R; Kugler JW
    Cancer; 2002 Apr; 94(8):2224-31. PubMed ID: 12001121
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Results of primary chemotherapy in 44 patients with advanced squamous cell carcinoma in the area of the head and neck].
    von Heyden HW; Schröder M; Scherpe A; Stennert E; Beyer JH; Nagel GA; Hoffmann H; Schneider B
    HNO; 1984 Nov; 32(11):454-9. PubMed ID: 6210278
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chemotherapy for head and neck cancer. Comparison of cisplatin + vinblastine + bleomycin versus methotrexate.
    Williams SD; Velez-Garcia E; Essessee I; Ratkin G; Birch R; Einhorn LH
    Cancer; 1986 Jan; 57(1):18-23. PubMed ID: 2416423
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chemotherapy of squamous head and neck cancer: a prospective randomized trial comparing cis-platinum and bleomycin with methotrexate and vindesine.
    von Heyden HW; Schröder M; Scherpe A; Borghardt J; Beyer JH; Nagel GA; Gerhartz H; Foth B; Kastenbauer E; Westerhausen M
    Recent Results Cancer Res; 1985; 98():148-52. PubMed ID: 2412266
    [No Abstract]   [Full Text] [Related]  

  • 9. [Chemotherapy of head and neck squamous cell cancer with vindesine (Eldesine) and cis-platinum (Platinex) (author's transl)].
    Ruffmann R; Seifert R; Ross H; Sturm E
    Laryngol Rhinol Otol (Stuttg); 1982 Jul; 61(7):406-10. PubMed ID: 7202092
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Experiences using combination chemotherapy with cis-platinum, bleomycin and methotrexate in the management of advanced squamous cell carcinomas of the head and neck (author's transl)].
    Jahnke V
    HNO; 1980 Dec; 28(12):405-8. PubMed ID: 6161913
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Continuous vindesine infusion in advanced head and neck cancer.
    Popkin JD; Bromer RH; Vaughan CW; Byrne RE; Licciardello JT; Hoffer SM; Welch JM; Fofonoff SA; Strong MS; Hong WK
    Am J Clin Oncol; 1983 Jun; 6(3):301-4. PubMed ID: 6846248
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Phase-II study of cis-diammine-dichloro platinum (cis-platinum), bleomycin and methotrexate for advanced squamous cell carcinoma of head and neck.
    Espana P; Smith F; Abrams J; Haidak D; Ueno W; Woolley P; Schein P
    Cancer Chemother Pharmacol; 1984; 12(2):98-100. PubMed ID: 6199132
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bleomycin and cis-platinum with or without mitomycin C in 110 previously untreated patients with head and neck cancer.
    Israel L; Aguilera J; Soudant J; Penot JC; Breau JL; Morere JF
    Am J Clin Oncol; 1983 Jun; 6(3):305-11. PubMed ID: 6189388
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A randomized trial of the combination of cis-platinum, oncovin and bleomycin (COB) versus methotrexate in patients with advanced squamous cell carcinoma of the head and neck.
    Drelichman A; Cummings G; Al-Sarraf M
    Cancer; 1983 Aug; 52(3):399-403. PubMed ID: 6190548
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Second-line chemotherapy with bleomycin, methotrexate, and vinorelbine (BMV) for patients with squamous cell carcinoma of the head, neck and esophagus (SCC-HN&E) pretreated with a cisplatin-containing regimen: a phase II study.
    Moroni M; Giannetta L; Gelosa G; Secondino S; Chillura G; Colombo E; Siena S
    J Chemother; 2003 Aug; 15(4):394-9. PubMed ID: 12962369
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment of advanced epidermoid carcinoma of the head and neck using methotrexate, bleomycin and cis-platinum.
    Orsini MA; Strauss M; Zaino RJ; Messeih AA; Harvey HA; Lipton A
    Trans Pa Acad Ophthalmol Otolaryngol; 1984; 37(1):71-6. PubMed ID: 6204427
    [No Abstract]   [Full Text] [Related]  

  • 17. Combination chemotherapy with cisplatin, bleomycin, and methotrexate in patients with advanced head and neck cancer.
    Von Hoff DD; Alberts DS; Mattox DE; Coulthard S; Dana B; Manning M; Myers JW; Griffin CB
    Cancer Clin Trials; 1981; 4(2):215-8. PubMed ID: 6166408
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Randomized comparison of cis-diamminedichloroplatinum versus cis-diamminedichloroplatinum, methotrexate, and bleomycin in recurrent squamous cell carcinoma of the head and neck.
    Davis S; Kessler W
    Cancer Chemother Pharmacol; 1979; 3(1):57-9. PubMed ID: 93988
    [No Abstract]   [Full Text] [Related]  

  • 19. [Pathohistologic changes after induction cytostatic therapy with methotrexate (M), bleomycin (B) and cisplatin (P)--(MBP)].
    Böheim K; Mikuz G; Böheim C
    Laryngol Rhinol Otol (Stuttg); 1982 May; 61(5):246-50. PubMed ID: 6178922
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Indications for cytostatic therapy of recurrent cancer].
    Schröder M; Stennert E; von Heyden HW; Scherpe A
    HNO; 1984 Jun; 32(6):245-8. PubMed ID: 6206035
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.